PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 93 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $380 | -99.8% | 365,047 | +366.2% | 0.05% | +42.4% |
| Q1 2021 | $201,000 | +390.2% | 78,308 | +492.7% | 0.03% | +43.5% |
| Q2 2020 | $41,000 | -88.4% | 13,212 | -91.5% | 0.02% | -74.2% |
| Q1 2020 | $353,000 | -50.1% | 154,991 | -20.7% | 0.09% | +8.5% |
| Q4 2019 | $707,000 | +154.3% | 195,369 | +230.1% | 0.08% | +164.5% |
| Q2 2019 | $278,000 | -14.7% | 59,180 | -39.2% | 0.03% | -6.1% |
| Q1 2019 | $326,000 | +3.2% | 97,272 | -18.1% | 0.03% | -8.3% |
| Q4 2018 | $316,000 | -83.9% | 118,700 | -66.2% | 0.04% | -67.0% |
| Q3 2018 | $1,966,000 | +43.7% | 351,000 | +30.0% | 0.11% | +60.3% |
| Q2 2018 | $1,368,000 | +1100.0% | 269,900 | +1516.2% | 0.07% | +1033.3% |
| Q1 2018 | $114,000 | -9.5% | 16,700 | 0.0% | 0.01% | -25.0% |
| Q4 2017 | $126,000 | – | 16,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |